Test Price
2,800 AED✅ Home Collection Available
ANK2 Gene Long QT Syndrome Type 4 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✔ Diagnostic sensitivity of 99.9% via ISO‑certified NGS processing with full ANK2 gene coverage.
- ✔ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✔ Post‑test teleconsultation with a consultant medical geneticist for result interpretation.
- ✔ Direct insurance verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS)‑based genetic test sequences the entire ANK2 gene to diagnose Long QT Syndrome Type 4 (LQTS4). It enables precise risk stratification, cascade screening for at‑risk family members, and personalized cardiac management.
| Parameter | ANK2 NGS Test | Sanger Sequencing (Alternative) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; full gene coverage including intronic regions | ~95% sensitivity; limited to targeted exons |
| Method | Next Generation Sequencing (NGS) with copy number variant (CNV) detection | Sanger sequencing; cannot detect large deletions/duplications |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics (DHA 9294403), I emphasize that a positive ANK2 result must always be interpreted alongside the patient’s clinical phenotype and family history. A negative result does not eliminate the risk of inherited arrhythmias. This genetic test is a powerful tool, yet it does not replace a thorough cardiological workup.” – Lina Osama Zaki Quteineh
Advisory: Medication Safety
Critical Medication Precaution
Do not discontinue or modify any prescribed antiarrhythmic or beta‑blocker therapy without explicit consultation with your cardiologist. Abrupt changes can precipitate life‑threatening arrhythmias.
Exclusion Criteria & Emergency Red Flags
- Not intended for patients currently experiencing acute chest pain, syncope, or cardiac arrest.
- This test is not a substitute for emergency cardiac monitoring; if you suffer palpitations, fainting, or have a family history of sudden death, seek immediate medical attention.
- Genetic counselling is mandatory before sample collection to ensure appropriate test selection and interpretation.
- Results should only be disclosed by a certified cardiologist or clinical geneticist.
Patient FAQ & Clinical Guidance
1. What is the ANK2 gene test used for?
The ANK2 Genetic Test identifies mutations causing Long QT Syndrome Type 4 (LQTS4), a hereditary arrhythmia condition that can lead to sudden cardiac events. This comprehensive analysis helps cardiologists individualize treatment, recommend lifestyle modifications, and screen at‑risk family members.
2. How is the sample collected for this test?
A simple venous blood draw is required. Our VIP Mobile Phlebotomy service dispatches an ISO‑certified phlebotomist to your home between 8 AM and 11 PM. The sample is transported under temperature‑controlled cold‑chain conditions to preserve DNA integrity.
3. What do the results mean for my family?
LQTS4 is inherited in an autosomal dominant pattern. A positive result indicates a 50% chance for each first‑degree relative to carry the same mutation. Cascade testing is strongly recommended. Our genetic counsellor will guide you through communicating risks and arranging family screenings.
4. How long does it take to get results?
The turnaround time is 3–4 weeks from sample receipt. You will receive a comprehensive report including variant interpretation and clinical recommendations.
5. Is genetic counselling provided?
Yes, pre‑test and post‑test genetic counselling is mandatory. Our consultant medical geneticist will discuss the implications, benefits, and limitations of testing before sample collection and will interpret results in the context of your personal and family history.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and processed solely for diagnostic purposes. Laboratory operations are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
For billing or insurance verification, contact our support team via WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | ANK2 Gene Long QT Syndrome Type 4 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral Venous Blood) |
| Methodology Used | Next Generation Sequencing (NGS) with copy number variant detection |
| ICD-10-CM Code | I45.81 (Long QT syndrome), Z13.7 (Encounter for genetic testing), Z15.89 (Genetic susceptibility to other disease) |
| LOINC Code | 93723-0 (ANK2 gene full mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians